Silence Therapeutics, Plc. earnings per share and revenue

SLNCF earnings per share for the last quarter are -0.05 USD whereas the estimation was -0.04 USD which accounts for -24.47% surprise. Company revenue for the same period amounts to 756.05 k USD despite the estimated figure of 11.65 M USD. Estimated earnings per share for the next quarter are -0.04 USD, and revenue is expected to reach 5.85 M USD. Also watch annual changes over time to get a bigger picture of SLNCF earnings per share and revenue dynamics.